Back to News
Market Impact: 0.05
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Source: zacks.com
Healthcare & BiotechProduct Launches
The State Street SPDR S&P Pharmaceuticals ETF (XPH) debuted on June 19, 2006. The smart-beta ETF provides broad exposure to the Health Care ETFs category; the article reports no performance or market-impact data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Sovereign wealth funds' China and Hong Kong investments surge 190% after a bruising slump
- Apple's iPhone Duo in short supply — plus, the 2 stocks fueling an AI rebound
- Arcus Biosciences prices $250 million stock offering at $17.50
- Tesla stars Optimus robot production in California as profit falls 43%
- OpenAI to bring AI models to Google's cloud, in further expansion beyond Microsoft
- AstraZeneca says U.S. FDA approves rare kidney disease drug
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- State of Public Markets, June 2026: Higher for Longer Meets the AI Supercycle
- AI Research Tools With Exact Source Citations